PRESS ASSOCIATION: Targeting two faulty genes could be key in treating blood cancer – study

Daniel Wiseman

Division of Cancer Sciences (L5)

Press/Media: Research

Description

Targeting two faulty genes associated with a deadly form of blood cancer could help develop better treatments, scientists have said.

A new study, published in the journal Nature, suggests the mutated genes known as SRSF2 and IDH2 join forces to bring about acute myeloid leukaemia (AML) – an aggressive form of cancer in the white blood cells.

Period	2 Oct 2019

Media coverage

Title	Targeting two faulty genes could be key in treating blood cancer – study
Media name/outlet	Press Association
Media type	Web
Country/Territory	United Kingdom
Date	2/10/19
Description	Targeting two faulty genes associated with a deadly form of blood cancer could help develop better treatments, scientists have said. A new study, published in the journal Nature, suggests the mutated genes known as SRSF2 and IDH2 join forces to bring about acute myeloid leukaemia (AML) – an aggressive form of cancer in the white blood cells.
URL	https://home.bt.com/news/science-news/targeting-two-faulty-genes-could-be-key-in-treating-blood-cancer-study-11364399534876
Persons	Daniel Wiseman

View all 1

View less

Research Beacons, Institutes and Platforms

Cancer

Keywords

cancer
myeloid leukaemia